Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / 2021 - Page 19

Year: 2021

Moderna and Tabuk Pharmaceuticals partnered to commercialize  COVID-19 Vaccine in Saudi Arabia
Biotechnology | COVID-19 | Therapeutics | Vaccine

Moderna and Tabuk Pharmaceuticals partnered to commercialize COVID-19 Vaccine in Saudi Arabia

On Jun. 11, 2021, Moderna and Tabuk Pharmaceutical announced an agreement to commercialize the Moderna COVID-19 Vaccine and…

Read More Moderna and Tabuk Pharmaceuticals partnered to commercialize COVID-19 Vaccine in Saudi ArabiaContinue

FDA issued EUA for the Janssen COVID-19 vaccine manufactured at Emergent BioSolutions facility in Baltimore
COVID-19 | FDA | Life Science History

FDA issued EUA for the Janssen COVID-19 vaccine manufactured at Emergent BioSolutions facility in Baltimore

On Jun. 11, 2021, The FDA issued an emergency use authorization (EUA) for the Janssen COVID-19 vaccine, two…

Read More FDA issued EUA for the Janssen COVID-19 vaccine manufactured at Emergent BioSolutions facility in BaltimoreContinue

Novavax announces positive data from three complementary studies of COVID-19 Beta variant strain vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Novavax announces positive data from three complementary studies of COVID-19 Beta variant strain vaccine

On Jun. 11, 2021, Novavax announced preclinical and clinical data on the company’s original recombinant protein COVID-19 vaccine…

Read More Novavax announces positive data from three complementary studies of COVID-19 Beta variant strain vaccineContinue

Novan announced positive ppreclinical data in SB019 COVID-19 anti-viral therapy program
COVID-19 | Life Science History

Novan announced positive ppreclinical data in SB019 COVID-19 anti-viral therapy program

On Jun. 10, 2021, Novan announced positive preclinical results with berdazimer sodium in a SARS-CoV-2 transmission model in…

Read More Novan announced positive ppreclinical data in SB019 COVID-19 anti-viral therapy programContinue

Moderna filed for Emergency Use Authorization for its COVID-19 vaccine in adolescents in the United States
Biotechnology | COVID-19 | FDA | Infectious Disease | Vaccine

Moderna filed for Emergency Use Authorization for its COVID-19 vaccine in adolescents in the United States

On Jun. 10, 2021, Moderna announced that it had requested an emergency use authorization (EUA) for its COVID-19…

Read More Moderna filed for Emergency Use Authorization for its COVID-19 vaccine in adolescents in the United StatesContinue

Pfizer and BioNTech provided 500 million doses of COVID-19 vaccine to U.S. Government for donation to poorest nations
COVID-19 | Life Science History | Vaccine

Pfizer and BioNTech provided 500 million doses of COVID-19 vaccine to U.S. Government for donation to poorest nations

On Jun. 10, 2021, Pfizer and BioNTech announced plans to provide the U.S. government at a not-for-profit price…

Read More Pfizer and BioNTech provided 500 million doses of COVID-19 vaccine to U.S. Government for donation to poorest nationsContinue

Vertex announces FDA approval for TRIKAFTAᆴ in children with Cystic Fibrosis ages 6 through 11 with certain mutations
FDA | Life Science History

Vertex announces FDA approval for TRIKAFTAᆴ in children with Cystic Fibrosis ages 6 through 11 with certain mutations

On Jun. 9, 2021, Vertex Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) approved expanded use of…

Read More Vertex announces FDA approval for TRIKAFTAᆴ in children with Cystic Fibrosis ages 6 through 11 with certain mutationsContinue

Roche obtained CE mark for SARS-CoV-2 antigen self test nasal allowing for rapid self testing of COVID-19 at home
Life Science History

Roche obtained CE mark for SARS-CoV-2 antigen self test nasal allowing for rapid self testing of COVID-19 at home

On Jun. 8, 2021, Roche announced it had received CE mark for its SARS-CoV-2 Antigen Self Test Nasal…

Read More Roche obtained CE mark for SARS-CoV-2 antigen self test nasal allowing for rapid self testing of COVID-19 at homeContinue

Merck announced supply agreement with U.S. Government for molnupiravir, an Investigational oral antiviral treatment of COVID-19
COVID-19 | Life Science History

Merck announced supply agreement with U.S. Government for molnupiravir, an Investigational oral antiviral treatment of COVID-19

On Jun. 8, 2021, Merck announced it had entered into a procurement agreement with the U.S. government for…

Read More Merck announced supply agreement with U.S. Government for molnupiravir, an Investigational oral antiviral treatment of COVID-19Continue

RECOVERY trial found aspirin does not improve survival for patients hospitalised with COVID-19
Biotechnology | COVID-19 | Diagnostics | FDA | Infectious Disease | Neurology | Pharmaceutical

RECOVERY trial found aspirin does not improve survival for patients hospitalised with COVID-19

On Jun. 8, 2021, the University of Oxford announced that the RECOVERY trial found aspirin does not improve…

Read More RECOVERY trial found aspirin does not improve survival for patients hospitalised with COVID-19Continue

Twist Bioscience began shipping of synthetic RNA controls for Kappa (B.1.617.1) SARS-CoV-2 variants
Biotechnology | COVID-19 | Diagnostics | Therapeutics | Vaccine

Twist Bioscience began shipping of synthetic RNA controls for Kappa (B.1.617.1) SARS-CoV-2 variants

On Jun. 8, 2021, Twist Bioscience announced that it had started shipping its synthetic RNA reference controls for…

Read More Twist Bioscience began shipping of synthetic RNA controls for Kappa (B.1.617.1) SARS-CoV-2 variantsContinue

Senolytics reduced COVID-19 symptoms in preclinical studies
Biotechnology | COVID-19 | Infectious Disease | Therapeutics | Veterinary

Senolytics reduced COVID-19 symptoms in preclinical studies

On Jun. 8, 2021, Mayo Clinic researchers and colleagues at the University of Minnesota showed that COVID-19 exacerbates…

Read More Senolytics reduced COVID-19 symptoms in preclinical studiesContinue

Pixel by Labcorpᆴ COVID-19 PCR test home collection kits now available nationwide
COVID-19 | Life Science History

Pixel by Labcorpᆴ COVID-19 PCR test home collection kits now available nationwide

On Jun. 8, 2021, LabCorp announced that its Pixel COVID-19 PCR Test Home Collection Kits were availavle in…

Read More Pixel by Labcorpᆴ COVID-19 PCR test home collection kits now available nationwideContinue

FDA approved PREVNAR 20ル, Pfizerメs pneumococcal 20-valent conjugate vaccine for adults ages 18 years or older
CDC | Life Science History

FDA approved PREVNAR 20ル, Pfizerメs pneumococcal 20-valent conjugate vaccine for adults ages 18 years or older

On Jun. 8, 2021, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved PREVNAR 20ル…

Read More FDA approved PREVNAR 20ル, Pfizerメs pneumococcal 20-valent conjugate vaccine for adults ages 18 years or olderContinue

INOVIO expanded partnership with Advaccine to conduct global phase 3 efficacy trial of COVID-19 DNA vaccine candidate
Biotechnology | COVID-19 | Infectious Disease | Vaccine

INOVIO expanded partnership with Advaccine to conduct global phase 3 efficacy trial of COVID-19 DNA vaccine candidate

On Jun. 8, 2021, Inovio Pharma announced an expansion of its previously announced partnership with Advaccine Biopharmaceuticals to…

Read More INOVIO expanded partnership with Advaccine to conduct global phase 3 efficacy trial of COVID-19 DNA vaccine candidateContinue

Study suggested no association between antiseizure drugs used during pregnancy and neurodevelopmental problems in children at age 2
Life Science History

Study suggested no association between antiseizure drugs used during pregnancy and neurodevelopmental problems in children at age 2

On Jun. 7, 2021, the National Institutes of Health announced new findings published in JAMA Neurology that suggested…

Read More Study suggested no association between antiseizure drugs used during pregnancy and neurodevelopmental problems in children at age 2Continue

MediciNova initiated sheep study under BARDA to develop MN-166 (ibudilast) as countermeasure against chlorine
Biotechnology | Chemical | Infectious Disease | Therapeutics

MediciNova initiated sheep study under BARDA to develop MN-166 (ibudilast) as countermeasure against chlorine

On Jun. 7, 2021, MediciNova announced it had initiated a sheep study to investigate MN-166 (ibudilast) in an…

Read More MediciNova initiated sheep study under BARDA to develop MN-166 (ibudilast) as countermeasure against chlorineContinue

FDA granted accelerated approval for ADUHELMル as the first and only Alzheimerメs disease treatment
FDA | Life Science History

FDA granted accelerated approval for ADUHELMル as the first and only Alzheimerメs disease treatment

On Jun. 7, 2021, Biogen and Eisai announced that the U.S. Food and Drug Administration (FDA) had granted…

Read More FDA granted accelerated approval for ADUHELMル as the first and only Alzheimerメs disease treatmentContinue

Moderna filed for conditional Marketing Approval for its COVID-19 vaccine in adolescents in the EU
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna filed for conditional Marketing Approval for its COVID-19 vaccine in adolescents in the EU

On Jun. 7, 2021, Moderna announced that it had submitted for a conditional marketing approval (CMA) for its…

Read More Moderna filed for conditional Marketing Approval for its COVID-19 vaccine in adolescents in the EUContinue

Moderna and Medison Pharma partnered to commercialize COVID-19 vaccine in Central Eastern Europe and Israel
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna and Medison Pharma partnered to commercialize COVID-19 vaccine in Central Eastern Europe and Israel

On Jun. 7, 2021, Moderna announced a new agreement to commercialize its COVID-19 Vaccine across Central Eastern Europe…

Read More Moderna and Medison Pharma partnered to commercialize COVID-19 vaccine in Central Eastern Europe and IsraelContinue

OraSure Technologies receives three EUA’s for its COVID-19 rapid antigen tests for non-prescription use
COVID-19 | FDA | Life Science History

OraSure Technologies receives three EUA’s for its COVID-19 rapid antigen tests for non-prescription use

On Jun. 7, 2021, OraSure Technologies announced that it had received Emergency Use Authorization (EUA) from the FDA…

Read More OraSure Technologies receives three EUA’s for its COVID-19 rapid antigen tests for non-prescription useContinue

FDA approved new rug treatment for chronic weight management, first since 2014
FDA | Life Science History

FDA approved new rug treatment for chronic weight management, first since 2014

On Jun. 4, 2021, the U.S. Food and Drug Administration announced it had approved Novo Nordisk’s Wegovy (semaglutide)…

Read More FDA approved new rug treatment for chronic weight management, first since 2014Continue

FDA approved new drug treatment for chronic weight management, first since 2014
Life Science History

FDA approved new drug treatment for chronic weight management, first since 2014

On Jun. 4, 2021, the U.S. Food and Drug Administration approved Novo Nordisk’s Wegovy (semaglutide) injection (2.4 mg…

Read More FDA approved new drug treatment for chronic weight management, first since 2014Continue

Chimerix received U.S. FDA approval for TEMBEXAᆴ (brincidofovir) for treatment of smallpox
FDA | Life Science History

Chimerix received U.S. FDA approval for TEMBEXAᆴ (brincidofovir) for treatment of smallpox

On Jun. 4, 2021, Chimerix announced that the U.S. Food and Drug Administration (FDA) had granted TEMBEXAᆴ (brincidofovir)…

Read More Chimerix received U.S. FDA approval for TEMBEXAᆴ (brincidofovir) for treatment of smallpoxContinue

FDA authorized lower 1,200 mg intravenous and subcutaneous dose of REGEN-COV antibody cocktail to treat COVID-19 patients
Biotechnology | FDA | Therapeutics

FDA authorized lower 1,200 mg intravenous and subcutaneous dose of REGEN-COV antibody cocktail to treat COVID-19 patients

On Jun. 4, 2021, Regeneron announced the U.S. Food and Drug Administration (FDA) updated the Emergency Use Authorization…

Read More FDA authorized lower 1,200 mg intravenous and subcutaneous dose of REGEN-COV antibody cocktail to treat COVID-19 patientsContinue

Resverlogix and EVERSANA announced partnership to support commercialization of Apabetalone for COVID-19 in U.S. and Canada
COVID-19 | Life Science History

Resverlogix and EVERSANA announced partnership to support commercialization of Apabetalone for COVID-19 in U.S. and Canada

On Jun. 3, 2021, Resverlogix announced a partnership to support planned commercialization of apabetalone in the United States,…

Read More Resverlogix and EVERSANA announced partnership to support commercialization of Apabetalone for COVID-19 in U.S. and CanadaContinue

NIH researchers identified potential new antiviral drug for COVID-19
COVID-19 | Life Science History | NIH

NIH researchers identified potential new antiviral drug for COVID-19

On Jun. 3, 2021, the National Institutes of Health announced that the experimental drug TEMPOL may be a…

Read More NIH researchers identified potential new antiviral drug for COVID-19Continue

Innovation Pharma completed enrollment in phase 2 clinical trial for COVID-19
COVID-19 | FDA | Life Science History

Innovation Pharma completed enrollment in phase 2 clinical trial for COVID-19

On Jun. 3, 2021, Innovation Pharma announced that it had achieved full patient enrollment in its randomized, double-blind,…

Read More Innovation Pharma completed enrollment in phase 2 clinical trial for COVID-19Continue

Moderna announced agreement to supply the Republic of Botswana with COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced agreement to supply the Republic of Botswana with COVID-19 vaccine

On Jun. 3, 2021, Moder’s vaccine against COVID-19, to support the government’s ongoing efforts to secure access to…

Read More Moderna announced agreement to supply the Republic of Botswana with COVID-19 vaccineContinue

Lonza and Moderna announced collaboration for drug substance manufacturing of COVID-19 Vaccine in the Netherlands
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Lonza and Moderna announced collaboration for drug substance manufacturing of COVID-19 Vaccine in the Netherlands

On Jun. 2, 2021, Lonza announced the expansion of its collaboration with Moderna. The expanded collaboration extended the…

Read More Lonza and Moderna announced collaboration for drug substance manufacturing of COVID-19 Vaccine in the NetherlandsContinue

Page navigation

Previous PagePrevious 1 … 17 18 19 20 21 … 40 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search